4.6 Review

Intravesical Therapy for Upper Urinary Tract Urothelial Carcinoma: A Comprehensive Review

Related references

Note: Only part of the references are listed.
Article Oncology

Effect of Adjuvant Systemic Chemotherapy on Intravesical Recurrence After Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Noriya Yamaguchi et al.

Summary: This study retrospectively analyzed the medical records of 133 patients with upper urinary tract urothelial carcinoma and found that adjuvant systemic chemotherapy after surgery can reduce the risk of intravesical recurrence.

ANTICANCER RESEARCH (2023)

Article Urology & Nephrology

Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline

Jonathan A. Coleman et al.

Summary: The purpose of this guideline is to provide a useful reference on the effective evidence-based diagnoses and management of non-metastatic upper tract urothelial carcinoma (UTUC). By conducting searches and analyzing medical literature, updated evidence-based recommendations regarding diagnosis and treatment of UTUC have been provided. Future studies will further support these recommendations to improve patient outcomes.

JOURNAL OF UROLOGY (2023)

Article Urology & Nephrology

Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes

Jennifer Linehan et al.

European Urology Focus (2023)

Review Urology & Nephrology

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update

Morgan Roupret et al.

Summary: The European Association of Urology has updated the guidelines for the management of upper urinary tract urothelial carcinoma. The recommendations are based on a systematic review of the literature and assessed by a panel of experts. However, there is still insufficient high-level evidence in many areas to provide strong recommendations.

EUROPEAN UROLOGY (2023)

Article Urology & Nephrology

Impact of diagnostic ureteral catheterization on intravesical tumour recurrence following radical nephroureterectomy for upper tract urothelial carcinoma

Ichiro Yonese et al.

Summary: This study aimed to investigate whether even a minimally invasive diagnostic procedure like ureteral catheterization (UCath) could significantly increase the risk of intravesical recurrence (IVR) in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy (RNU). A retrospective study enrolled 163 patients undergoing RNU for UTUC between 2010 and 2021. The results showed that UCath was significantly associated with IVR and shorter IVR-free survival (IVRFS) in UTUC patients.

WORLD JOURNAL OF UROLOGY (2023)

Article Urology & Nephrology

Antegrade Instillation of UGN-101 (Mitomycin for Pyelocalyceal Solution) for Low-Grade Upper Tract Urothelial Carcinoma: Initial Clinical Experience

Geoffrey H. Rosen et al.

Summary: This study presents the technique and early outcomes of antegrade administration of UGN-101 for low-grade upper tract urothelial carcinoma. Adverse events and ureteral strictures are discussed. The method shows potential to improve patient comfort, streamline the procedure, and reduce the risk of adverse events.

JOURNAL OF UROLOGY (2022)

Article Urology & Nephrology

Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report

Surena F. Matin et al.

Summary: The study aimed to evaluate the long-term safety and durability of UGN-101 as a primary chemoablative treatment for low-grade upper tract urothelial carcinoma. The results showed that UGN-101 has a clinically meaningful durability of response, providing a kidney-sparing therapeutic alternative for patients with low-grade disease.

JOURNAL OF UROLOGY (2022)

Review Urology & Nephrology

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

Marko Babjuk et al.

Summary: The updated EAU guidelines provide new information on the diagnosis and treatment of NMIBC for clinical practice. Individual risk assessment is crucial in determining the appropriate treatment for patients with different risk levels. Surgical intervention, including radical cystectomy, may be necessary for cases unresponsive to BCG treatment or with high risk of progression.

EUROPEAN UROLOGY (2022)

Review Urology & Nephrology

Genitourinary manifestations of Lynch syndrome in the urological practice

Chiara Lonati et al.

Summary: This study provides a comprehensive overview of the genitourinary manifestations of Lynch syndrome (LS), focusing on the incidence, diagnosis, clinical features, therapeutic strategies, and screening protocols. Upper tract urothelial carcinoma (UTUC) is the most common cancer in the urological field among LS patients. The diagnosis of LS among UTUC patients is a step-by-step process involving clinical criteria, molecular testing, and genetic testing. The European Association of Urology (EAU) guidelines recommend molecular testing for specific groups of UTUC patients. Multidisciplinary management is important for newly diagnosed LS patients. Further research is needed to determine the role of LS in bladder cancer, prostate cancer, and renal cell carcinoma.

ASIAN JOURNAL OF UROLOGY (2022)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Urology & Nephrology

Higher than expected and significantly increasing incidence of upper tract urothelial carcinoma. A population based study

Bjarte Almas et al.

Summary: The incidence of UTUC was higher than expected and increasing, with patient age at diagnosis increasing as well. The cancer-specific survival rate has improved over the years.

WORLD JOURNAL OF UROLOGY (2021)

Article Andrology

Impact of previous, simultaneous or intravesical recurrence bladder cancer on prognosis of upper tract urothelial carcinoma after nephroureterectomy: a large population-based study

Shuxiong Zeng et al.

Summary: In UTUC patients, previous or simultaneous bladder cancer, IVR with MIBC, and a shorter interval between UTUC and IVR were significant predictors for worse prognosis. More stringent postoperative surveillance and active treatment strategies should be considered for UTUC patients with those risk factors.

TRANSLATIONAL ANDROLOGY AND UROLOGY (2021)

Article Urology & Nephrology

Intraoperative Mitomycin C Bladder Installation During Radical Nephroureterectomy Is Feasible and Safe

Naomi Nadler et al.

Summary: Bladder recurrence following radical treatment of upper urinary tract cancer is common, and the intraoperative use of MMC for bladder instillation appears to be safe and feasible without increasing complication rates.

EUROPEAN UROLOGY OPEN SCIENCE (2021)

Review Urology & Nephrology

Molecular markers of systemic therapy response in urothelial carcinoma

Francesco Claps et al.

Summary: Identifying reliable molecular biomarkers to complement clinical practice is a challenging task, particularly in the heterogeneous disease of urothelial carcinoma. Advances in molecular biology offer promising platforms to understand the biology behind the disease.

ASIAN JOURNAL OF UROLOGY (2021)

Review Urology & Nephrology

The emerging role of somatic tumor sequencing in the treatment of urothelial cancer

Lexiaochuan Wen et al.

Summary: The advancement of rapid genome sequencing has improved our understanding of the molecular biology of malignancies, particularly highlighting the individualistic nature of tumors and revolutionizing therapeutic approaches through whole exome sequencing. Whole genome sequencing of urothelial malignancies has identified somatic mutations contributing to cancer growth, progression, and metastasis, paving the way for development of targeted therapeutic agents. The ongoing genetic sequencing allows for identification of additional targets and personalized treatment based on the mutational profile of each patient's malignancy.

ASIAN JOURNAL OF UROLOGY (2021)

Review Oncology

Genetic Differences Between Bladder and Upper Urinary Tract Carcinoma: Implications for Therapy

John P. Sfakianos et al.

Summary: Urothelial carcinoma of the bladder and upper tract urothelial carcinoma share mutations in similar genes but at different frequencies, which likely contribute to their distinct behaviors and metachronous recurrences. Tailored treatment options specific to tumors of different locations based on their genomic features are recommended.

EUROPEAN UROLOGY ONCOLOGY (2021)

Article Urology & Nephrology

Oncological outcomes of radical nephroureterectomy for upper urinary tract urothelial neoplasia in Denmark

Nessn H. Azawi et al.

SCANDINAVIAN JOURNAL OF UROLOGY (2020)

Article Oncology

Intraoperative prophylactic intravesical chemotherapy to reduce bladder recurrence following radical nephroureterectomy

Yuval Freifeld et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)

Review Oncology

Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature

Beat Foerster et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)

Review Urology & Nephrology

Understanding the biology of urothelial cancer metastasis

Takashi Kobayashi

ASIAN JOURNAL OF UROLOGY (2016)

Article Urology & Nephrology

Percutaneous resection of upper tract urothelial cell carcinoma: When, how, and is it safe?

Willem E. Strijbos et al.

ASIAN JOURNAL OF UROLOGY (2016)

Article Oncology

Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma

Claudia P. Rojas et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)

Article Urology & Nephrology

Secondary bladder cancer after upper tract urothelial carcinoma in the US population

Max Kates et al.

BJU INTERNATIONAL (2012)

Article Oncology

Molecular evidence supporting field effect in urothelial carcinogenesis

TD Jones et al.

CLINICAL CANCER RESEARCH (2005)

Review Oncology

Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies

C Hafner et al.

INTERNATIONAL JOURNAL OF CANCER (2002)